Fundraising Fox

R G Boyle

Investor

Independent Representative of the Investment Advisory Panel at O2h Ventures

Greater Cambridge Area

About

Founder and CEO of Sentinel Oncology, a medicinal chemist with 25+ years of industry experience at Pfizer, Millennium, and Astex. He is a named inventor on 50+ patents and publications on small-molecule therapeutics.

Experience

  1. Sentinel OncologyCEOcurrent2005 — present
  2. Oxford Drug DesignBoard Membercurrent2019 — presentOxford, United Kingdom
  3. o2h Ventures LimitedVenture Partnercurrent2019 — presentCambridge, United Kingdom
  4. NeoPhore LtdDirector2017 — 2019Cambridge, United Kingdom
  5. Astex PharmaceuticalsSenior Research Associate2003 — 2005
  6. Millennium PharmaceuticalsSr Scientist II2000 — 2003
  7. Cambridge Discovery ChemistryGroup Leader1997 — 2000
  8. PfizerAssociate Scientist1993 — 1997

Skills & more

Drug Discovery62Medicinal Chemistry32Organic Chemistry21Biotechnology40Oncology14Lifesciences15Drug Development22Chemistry17Leadership5CRO4Technology Transfer8Drug Design7
+6 moreClinical DevelopmentADMEPharmacologyLife SciencesPharmaceutical IndustryCRO Management

From R's professional profile.

Colleagues at O2h Ventures

Frequently asked questions

Where does R G Boyle work?
R G Boyle is Independent Representative of the Investment Advisory Panel at O2h Ventures.

Shared employers